New hope for hard-to-treat gut cancers: targeted combo tested
NCT ID NCT05039177
First seen Mar 28, 2026 · Last updated May 02, 2026 · Updated 4 times
Summary
This study tested a new drug called ERAS-007 combined with other cancer treatments in 101 people with advanced colorectal or pancreatic cancer that had spread. The main goals were to find the safest dose and check for side effects. The approach targets a specific cell pathway (MAPK) to try to control tumor growth.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC COLORECTAL CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
City of Hope
Duarte, California, 91010, United States
-
Duke Cancer Institute
Durham, North Carolina, 27710, United States
-
Henry Ford Cancer Institute
Detroit, Michigan, 48202, United States
-
Massachusetts General Hospital
Boston, Massachusetts, 02215, United States
-
Sarah Cannon Research Institute (Tennessee Oncology)
Nashville, Tennessee, 37203, United States
-
Stephenson Cancer Center
Oklahoma City, Oklahoma, 73104, United States
-
The Johns Hopkins Hospital
Baltimore, Maryland, 21287, United States
-
The University of Texas MD Anderson Cancer Center
Houston, Texas, 77030, United States
-
UCSF Mount Zion Medical Ctr
San Francisco, California, 94158, United States
-
University of Alabama at Birmingham (O'Neal Comprehensive Cancer Center)
Birmingham, Alabama, 35233, United States
-
University of California Irvine College of Medicine
Orange, California, 92868, United States
-
University of Washington - Seattle Cancer Care Alliance
Seattle, Washington, 98109, United States
-
Virginia Cancer Specialists
Fairfax, Virginia, 22031, United States
-
Washington University (Siteman Cancer Center)
St Louis, Missouri, 63110, United States
Conditions
Explore the condition pages connected to this study.